FEATURE: An Overview of Uterine Cancer
Nathan D. Stice, M.D.
Uterine cancer is the most common gynecologic malignancy in the United States and the 4th leading new cancer diagnosis in females. This year, an estimated 63,230 women will be diagnosed with uterine cancer. There is an 81.1% five -year survival rate and early detection is the key. If the cancer is found in stage one, the five-year survival rate is 94.9%. New uterine cancer rates are increasing an average of 1.3% every year and has been for the past 10 years.
Unlike many other cancers, uterine cancer (specifically endometrial cancer) has warning signs and can lead to early diagnosis and early treatment, which often leads to a complete cure.
What is endometrial cancer?
The most common form of uterine cancer is also called endometrial cancer. The lining of the uterus is known as the endometrium, and is the layer of the uterus that sheds when a female is menstruating. These cells can undergo hyperplasia if not shed regularly. After many years, this hyperplasia can become endometrial cancer.
Click links below to see 2017 statistics on Uterine Cancer.